Anshu Li

机构：Union Hospital, Huazhong University of Science and Technology

发表论文 12 篇 · 总被引 174 次 · h-index 7

代表论文

• Neoadjuvant tislelizumab and tegafur/gimeracil/octeracil (S-1) plus oxaliplatin in patients with locally advanced gastric or gastroesophageal junction cancer: Early results of a phase 2, single-arm trial (2022 · Frontiers in Oncology · 被引 56)
• The Potential Role of IL1RAP on Tumor Microenvironment-Related Inflammatory Factors in Stomach Adenocarcinoma (2021 · Technology in Cancer Research & Treatment · 被引 23)
• circRNA_101277 Influences Cisplatin Resistance of Colorectal Cancer Cells by Modulating the miR-370/IL-6 Axis (2022 · Genetics Research · 被引 22)
• LncRNA LZTS1-AS1 induces proliferation, metastasis and inhibits autophagy of pancreatic cancer cells through the miR-532 /TWIST1 signaling pathway (2023 · Cancer Cell International · 被引 21)
• Influence of Bariatric Surgery on the Expression of Nesfatin-1 in Rats with Type 2 Diabetes Mellitus (2015 · Current Pharmaceutical Design · 被引 17)
• Two-Year Outcomes and Biomarker Analysis of Locally Advanced Gastric and Gastroesophageal Junction Adenocarcinoma After Neoadjuvant Chemotherapy and Immunotherapy from the Phase II WuhanUHGI001 Trial (2024 · Annals of Surgical Oncology · 被引 15)